Stock Analysis

ALNY

Alnylam Pharmaceuticals, Inc. · Healthcare

Win Score
54
Risk Score
46

Score History

Last 12 months
0255075100Jun 26Jul 26Aug 26Aug 26Sep 265446
Win ScoreRisk Score

In context

Its Win Score ranks above 57% of the 129 analysed Healthcare stocks in the same sector. The average Win Score in this sector is 53. Its Risk Score is more favourable than 62% of sector peers – a lower value is better.

More stocks in Healthcare

AMGNAmgen Inc.AMP.MIAmplifon S.p.A.ARWRArrowhead Pharmaceuticals, Inc.ATRAptarGroup, Inc.AVTRAvantor, Inc.AZN.LAstraZeneca PLCAZN.STAstraZeneca PLCBAXBaxter International Inc.BAYN.DEBayer AktiengesellschaftBDXBecton, Dickinson and CompanyBIIBBiogen Inc.BIOBio-Rad Laboratories, Inc.

All metrics and scores are for informational purposes only, identical for every user, and do not constitute investment advice or a recommendation to buy or sell.

Unlock the full analysis

Fundamentals, sector comparison, watchlist, and alerts for every scanned stock – sign up for free.

Sign up for free →